Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

Melatonin

Ultra-pure
 
BML-NS520-0001 1 g 57.00 USD
Do you need bulk/larger quantities?
 
Replaces Prod. #: ALX-550-071

Endogenous agonist at melatonin MT1 and MT2 receptors. Displays antioxidant and antiapoptotic effects in numerous cell types as well as beneficial effects in various neurodegenerative diseases. It protects neuronal cells from amyloid beta-mediated oxidative damage and increases survival in an Alzheimer’s disease transgenic mouse model. Melatonin directly inhibits mitochondrial permeability transition pore (IC50 = 0.8M) and reduced the loss of neurons in a rat model of transient brain ischemia.

Product Specification

Alternative Name:N-Acetyl-5-methoxytryptamine
 
Formula:C13H16N2O2
 
MW:232.3
 
CAS:73-31-4
 
MI:14: 5816
 
RTECS:AC5955000
 
Purity:≥98% (HPLC)
 
Identity:Determined by 1H-NMR and MS.
 
Appearance:White to off-white powder.
 
Solubility:Soluble in dilute aqueous acid, methanol or 100% ethanol.
 
Shipping:Ambient
 
Long Term Storage:-20°C
 
Handling:Protect from light.
 
550-071
Please mouse over
550-071

Product Literature References

Melatonin and nitric oxide: S. Aydogan, et al.; J. Endocrinol. Invest. 29, 281 (2006), (Review), Abstract;
Melatonin inhibits endothelial nitric oxide production in vitro: E.K. Tamura, et al.; J. Pineal. Res. 41, 267 (2006), Abstract;
Melatonin suppresses macrophage cyclooxygenase-2 and inducible nitric oxide synthase expression by inhibiting p52 acetylation and binding: W.G. Deng, et al.; Blood 108, 518 (2006), Abstract;
Direct inhibition of the mitochondrial permeability transition pore: a possible mechanism responsible for anti-apoptotic effects of melatonin: S.A. Andrabi, et al.; FASEB J. 18, 869 (2004), Abstract;
Melatonin increases survival and inhibits oxidative and amyloid pathology in a transgenic model of Alzheimer’s disease: E. Matsubara, et al.; J. Neurochem. 85, 1101 (2003), Abstract;
Melatonin protects against ischemia-reperfusion injury and inhibits apoptosis in isolated working rat heart: P. Dobsak, et al.; Patophysiology 9, 179 (2003), Abstract;
Mitochondrial regulation by melatonin and its metabolites: D. Acuna-Castroviejo, et al.; Adv. Exp. Med. Biol. 527, 549 (2003), (Review), Abstract;
Melatonin suppresses NO-induced apoptosis via induction of Bcl-2 expression in PGT-beta immortalized pineal cells: Y.M. Yoo, et al.; J. Pineal. Res. 33, 146 (2002), Abstract;
Nitrosation of melatonin by nitric oxide and peroxynitrite: B. Blanchard, et al.; J. Pineal. Res. 29, 184 (2000), Abstract;
Interactions between melatonin, reactive oxygen species, and nitric oxide: D.K. Lahiri & C. Ghosh; Ann. N. Y. Acad. Sci. 893, 325 (1999), Abstract;
Melatonin as a pharmacological agent against neuronal loss in experimental models of Huntington’s disease, Alzheimer’s disease and parkinsonism: R.J. Reiter, et al.; Ann. N.Y. Acad. Sci. 890, 471 (1999), Abstract;
The oxidant/antioxidant network: role of melatonin: R.J. Reiter, et al.; Biol. Signals Recept. 8, 56 (1999), (Review), Abstract;
Melatonin inhibits expression of the inducible isoform of nitric oxide synthase in murine macrophages: role of inhibition of NFkappaB activation: E. Gilad, et al.; FASEB J. 12, 685 (1998), Abstract; Full Text
Oxidative damage in the central nervous system: protection by melatonin: R.J. Reiter; Prog. Neurobiol. 56, 359 (1998), Abstract;
Inhibition of cerebellar nitric oxide synthase and cyclic GMP production by melatonin via complex formation with calmodulin: D. Pozo, et al.; J. Cell Biochem. 65, 430 (1997), Abstract;
Melatonin is a scavenger of peroxynitrite: E. Gilad, et al.; Life Sci. 60, PL169 (1997), Abstract;
Melatonin receptors step into the light: cloning and classification of subtypes: S.M. Reppert, et al.; TIPS 17, 100 (1996), (Review), Abstract;
Melatonin comes of age?: R.M. Hagan & N.R. Oakley; TIPS 16, 81 (1995), (Review), Abstract;
Melatonin madness: S.M. Reppert & D.R. Weaver; Cell 83, 1059 (1995), (Minireview), Abstract;
Melatonin receptors: are there multiple subtypes?: M.L. Dubocovich; TIPS 16, 50 (1995), (Review), Abstract;
Physiological concentrations of melatonin inhibit nitric oxide synthase in rat cerebellum: D. Pozo, et al.; Life Sci. 55, PL455 (1994), Abstract;

Related Literature

Brochures
Essential Research Tools for Neurodegeneration & Neural Signaling
Essential Research Tools for Neurodegeneration & Neural Signaling
Download as PDF

All new literature pieces

Recommend this page

 
For Research Use Only. Not for use in diagnostic procedures.
Keep in touch

©2017 Enzo Life Sciences, Inc.,